| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 3 887-894, Copyright © 1996 by American Association of Immunologists
ARTICLES |
J Bliss, V Van Cleave, K Murray, A Wiencis, M Ketchum, R Maylor, T Haire, C Resmini, AK Abbas and SF Wolf
Genetics Institute Inc., Cambridge, MA 02140, USA.
IL-12 is a potent inducer of NK and cytolytic T cell activity, IFN- gamma production, and T cell proliferation, and is necessary for differentiation of naive T cells to the Th1 subset. We have previously shown that IL-12 promotes a primary Th1 response and suppresses a primary Th2 response in lymph nodes of mice primed with a model hapten- protein conjugate, 2,4,6-trinitrophenyl (TNP)-keyhole limpet hemocyanin (KLH). We have now extended these studies to determine the Th phenotype of the recall response following immunization with soluble Ag and IL- 12. For these experiments, mice were primed with TNP-KLH with or without treatment with IL-12, allowed to progress beyond the primary immune response, and challenged by i.p. injection of TNP-KLH. The phenotype of the recall response was monitored by measuring ex vivo production of IFN-gamma and IL-4 in Ag-stimulated lymph node and spleen cell cultures. Titer and isotype of TNP-specific serum Abs were also evaluated. Mice primed with Ag+IL-12 developed a Th1 recall response, as detected by KLH-specific IFN-gamma production from cultured spleen cells and the presence of TNP-specific IgG2a Ab in serum. However, they also developed an Ag-specific Th2 recall response, as characterized by Ag-induced IL-4 production from spleen cells and the presence of high titers of anti-TNP IgG1 in the serum. Studies of the cytokine profile during the primary response revealed that IL-12 induced in spleen cells the capacity to express both IL-4 and IFN-gamma. CD4+ T cells are necessary for production of IL-4 in the spleens of IL-12-treated mice, and most likely account for the Th2 recall response detected in mice primed with Ag+IL-12. These results indicate that the Th1 phenotype induced by immunization with IL-12 and Ag is maintained so that a Th1 recall response is expressed upon subsequent challenge with Ag. However, immunization with IL-12 also supports the development of a Th2 recall response, indicating that the Th1-inducing effect of IL-12 in vivo is not accompanied by a long lasting suppression of Th2 development.
This article has been cited by other articles:
|
|
 |
|
  H. K. Parmentier, L. Star, S. C. Sodoyer, M. G. B. Nieuwland, G. De Vries Reilingh, A. Lammers, and B. Kemp Age- and Breed-Dependent Adapted Immune Responsiveness of Poultry to Intratracheal-Administered, Pathogen-Associated Molecular Patterns Poult. Sci., December 1, 2006; 85(12): 2156 - 2168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Toscano, A. G. Commodaro, J. M. Ilarregui, G. A. Bianco, A. Liberman, H. M. Serra, J. Hirabayashi, L. V. Rizzo, and G. A. Rabinovich Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses J. Immunol., May 15, 2006; 176(10): 6323 - 6332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Lopez, S. K. Adris, A. I. Bravo, Y. Chernajovsky, and O. L. Podhajcer IL-12 and IL-10 Expression Synergize to Induce the Immune-Mediated Eradication of Established Colon and Mammary Tumors and Lung Metastasis J. Immunol., November 1, 2005; 175(9): 5885 - 5894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Dakappagari, J. Pyles, R. Parihar, W. E. Carson, D. C. Young, and P. T. P. Kaumaya A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses J. Immunol., April 15, 2003; 170(8): 4242 - 4253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Garg and R. L. Tarleton Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection Infect. Immun., October 1, 2002; 70(10): 5547 - 5555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Arulanandam, J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity against Streptococcus pneumoniae Infection Infect. Immun., November 1, 2001; 69(11): 6718 - 6724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nishikomori, S. Gurunathan, K. Nishikomori, and W. Strober BALB/c Mice Bearing a Transgenic IL-12 Receptor {{beta}}2 Gene Exhibit a Nonhealing Phenotype to Leishmania major Infection Despite Intact IL-12 Signaling J. Immunol., June 1, 2001; 166(11): 6776 - 6783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Maecker, G. Hansen, D. M. Walter, R. H. DeKruyff, S. Levy, and D. T. Umetsu Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model J. Immunol., January 15, 2001; 166(2): 959 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Rempel, M. Wang, and K. T. HayGlass Failure of rIL-12 administration to inhibit established IgE responses in vivo is associated with enhanced IL-4 synthesis by non-B/non-T cells Int. Immunol., July 1, 2000; 12(7): 1025 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Arulanandam, J. N. Mittler, W. T. Lee, M. O'Toole, and D. W. Metzger Neonatal Administration of IL-12 Enhances the Protective Efficacy of Antiviral Vaccines J. Immunol., April 1, 2000; 164(7): 3698 - 3704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Tuo, G. H. Palmer, T. C. McGuire, D. Zhu, and W. C. Brown Interleukin-12 as an Adjuvant Promotes Immunoglobulin G and Type 1 Cytokine Recall Responses to Major Surface Protein 2 of the Ehrlichial Pathogen Anaplasma marginale Infect. Immun., January 1, 2000; 68(1): 270 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Schopf, J. L. Bliss, L. M. Lavigne, C. L. Chung, S. F. Wolf, and J. P. Sypek Interleukin-12 Is Capable of Generating an Antigen-Specific Th1-Type Response in the Presence of an Ongoing Infection-Driven Th2-Type Response Infect. Immun., May 1, 1999; 67(5): 2166 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Bungiro Jr., M. Goldberg, P. K. Suri, and P. M. Knopf Interleukin-12 as an Adjuvant for an Antischistosome Vaccine Consisting of Adult Worm Antigens: Protection of Rats from Cercarial Challenge Infect. Immun., May 1, 1999; 67(5): 2340 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nyindo, T. M. Kariuki, P. W. Mola, I. O. Farah, L. Elson, R. E. Blanton, and C. L. King Role of Adult Worm Antigen-Specific Immunoglobulin E in Acquired Immunity to Schistosoma mansoni Infection in Baboons Infect. Immun., February 1, 1999; 67(2): 636 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Erard, J. A. Garcia-Sanz, R. Moriggl, and M.-T. Wild Presence or Absence of TGF-{beta} Determines IL-4-Induced Generation of Type 1 or Type 2 CD8 T Cell Subsets J. Immunol., January 1, 1999; 162(1): 209 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Adam. D. Cohen, J. D. Boyer, and D. B. Weiner Modulating the immune response to genetic immunization FASEB J, December 1, 1998; 12(15): 1611 - 1626. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Buchanan, B. P. Arulanandam, and D. W. Metzger IL-12 Enhances Antibody Responses to T-Independent Polysaccharide Vaccines in the Absence of T and NK Cells J. Immunol., November 15, 1998; 161(10): 5525 - 5533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Yeung, R. S. Gieni, D. T. Umetsu, and R. H. DeKruyff Heat-Killed Listeria monocytogenes as an Adjuvant Converts Established Murine Th2-Dominated Immune Responses into Th1-Dominated Responses J. Immunol., October 15, 1998; 161(8): 4146 - 4152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Nguyen, G. Bigaignon, J. Van Broeck, M. Vercammen, T. N. Nguyen, M. Delmee, M. Turneer, S. F. Wolf, and J. P. Coutelier Acute and Chronic Phases of Toxoplasma gondii Infection in Mice Modulate the Host Immune Responses Infect. Immun., June 1, 1998; 66(6): 2991 - 2995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Kline, T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma J. Immunol., March 15, 1998; 160(6): 2555 - 2559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Belyakov, M. A. Derby, J. D. Ahlers, B. L. Kelsall, P. Earl, B. Moss, W. Strober, and J. A. Berzofsky Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge PNAS, February 17, 1998; 95(4): 1709 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Brusselle, J. C. Kips, R. A. Peleman, G. F. Joos, R. R. Devos, J. H. Tavernier, and R. A. Pauwels Role of IFN-gamma in the Inhibition of the Allergic Airway Inflammation Caused by IL-12 Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 767 - 771. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Gurunathan, D. L. Sacks, D. R. Brown, S. L. Reiner, H. Charest, N. Glaichenhaus, and R. A. Seder Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major J. Exp. Med., October 6, 1997; 186(7): 1137 - 1147. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
